Tower Research Capital LLC (Trc) Aytu Biopharma, Inc Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.15 - $4.0 $2,675 - $71,348	-17,837 Reduced 35.6%	32,267 $6,000
Q3 2022 Nov 10, 2022	BUY	$0.19 - $3.8 $1,611 - $32,235	8,483 Added 20.38%	50,104 $10,000
Q2 2022 Aug 15, 2022	BUY	$0.46 - $1.08 $6,531 - $15,333	14,198 Added 51.77%	41,621 $29,000
Q1 2022 May 12, 2022	SELL	$1.08 - $1.55 $1,828 - $2,624	-1,693 Reduced 5.81%	27,423 $30,000
Q4 2021 Feb 14, 2022	BUY	$1.35 - $2.95 $37,224 - $81,343	27,574 Added 1788.2%	29,116 $39,000
Q3 2021 Nov 15, 2021	SELL	$2.78 - $5.12 $25,689 - $47,313	-9,241 Reduced 85.7%	1,542 $4,000
Q2 2021 Aug 16, 2021	BUY	$4.73 - $7.56 $44,258 - $70,738	9,357 Added 656.17%	10,783 $54,000
Q1 2021 May 17, 2021	SELL	$6.23 - $9.88 $7,120 - $11,292	-1,143 Reduced 44.49%	1,426 $11,000
Q4 2020 Feb 16, 2021	BUY	$5.98 - $13.5 $15,362 - $34,681	2,569 New	2,569 $15,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $102M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.